SCHEMBL19635795

SCHEMBL19635795

N#CN1CCC[C@@H](n2nc(-c3ccc(CN4CCOCC4)cc3)c3c(N)ncnc32)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 4/20 0.61
JAK2 O60674 3/20 0.61
EGFR P00533 10/20 0.54
BTK Q06187 7/20 0.54
ITK Q08881 4/20 0.54
LCK P06239 2/20 0.54
JAK1 P23458 1/20 0.47
PIK3CD O00329 2/20 0.47
ABL1 P00519 2/20 0.47
HCK P08631 2/20 0.47
SRC P12931 2/20 0.47
KDR P35968 2/20 0.47
PIK3CA P42336 2/20 0.47
PIK3CB P42338 2/20 0.47
MTOR P42345 2/20 0.47
PIK3CG P48736 2/20 0.47
EPHB4 P54760 2/20 0.47
PRKDC P78527 2/20 0.47
PI4KB Q9UBF8 1/20 0.47
IGF1R P08069 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19635228 0.85 IGF1R (0.47) JAK3JAK2EGFRBTKITK
SCHEMBL19635812 0.84 JAK3 (0.60) JAK3JAK2EGFRBTKITK
SCHEMBL19635797 0.80 JAK2 (0.64) JAK3JAK2EGFRBTKITK
SCHEMBL19636023 0.80 JAK2 (0.64) JAK3JAK2EGFRBTKITK
SCHEMBL19635794 0.80 JAK3 (0.61) JAK3JAK2BTKITKJAK1
SCHEMBL17479775 0.79 BTK (0.74) JAK3EGFRBTKITKLCK
SCHEMBL19635666 0.79 JAK3 (0.72) JAK3JAK2EGFRBTKJAK1
SCHEMBL28399199 0.77 JAK2 (0.65) JAK3JAK2EGFRBTKITK
SCHEMBL28399202 0.77 JAK2 (0.65) JAK3JAK2EGFRBTKITK
SCHEMBL19635789 0.76 BTK (0.68) JAK3JAK2EGFRBTKITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017198049-A1 PYRAZOLOPYRIMIDINE DERIVATIVE AS BTK INHIBITOR AND PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION THEREOF 浙江予川医药科技有限公司 2017-11-23 WO disclosed